SK Biopharm to showcase wearable devices for epilepsy patients at CES 2023

Hwang Sun-gwan, vice president of SK Biopharmaceuticals’ R&D Innovation, talks about the company's wearable devices that will be showcased at the CES 2023 in Las Vegas on Jan. 5. [SK BIOPHARMACEUTICALS]

SK Biopharmaceuticals will showcase five wearable devices for epilepsy patients at the CES 2023 scheduled for Jan. 5 in Las Vegas.

The showcase will be the start of the biopharmaceutical company’s digital healthcare business.

The five devices under development are the Zero Glasses, Zero Wired, Zero Headband, Zero Earbud and Zero Headset. All are designed to offer real-time monitoring and data-driven seizure detection for patients with epilepsy.

“One of the biggest fear of epilepsy patients is that they may have a sudden seizure,” said Hwang Sun-gwan, vice president of SK Biopharmaceuticals’ R&D Innovation, during a press conference on Wednesday in central Seoul.

“We aim to alert patients in advance when they are in danger of having a seizure."

These wearable devices will be all compatible with the Zero App, which can collect patients’ real-time signals in the brain and let artificial intelligence analyze the data to find any possible predictable symptoms.

The company is expected to introduce prototypes of the devices at the CES, and will start clinical trials next year.

"SK has many IT companies that we can cooperate with on the technology, so it won’t take that long for SK Biopharmaceuticals to release the final product," Hwang said, though saying he can’t predict the specific time at the moment.

“We are pleased to share our digital healthcare vision through wearable devices that will enable us to take a leap forward in becoming a global healthcare solution provider,” said Hwang.

“Through our business transformation model, we aim to further augment our digital healthcare capacity so that can create value for our patients in the world.”

BY SARAH CHEA [chea.sarah@joongang.co.kr]